Cardiac and cerebral vascular disease treating medicine composition

A composition and medicine technology, applied in the field of medicine, achieves the effects of simple preparation process, lowering left ventricular end-diastolic pressure, and increasing myocardial blood supply

Inactive Publication Date: 2008-01-02
SHANDONG XUANZHU PHARMA TECH CO LTD
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] At present, the use of ginseng, notoginseng and trichosanthes or the interaction and compatibility of ginseng, notoginseng, trichosanthes and ginkgo biloba to prepare drugs for treating cardiovascular and cerebrovascular diseases has not been reported yet.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0085] Embodiment 1: the preparation of pharmaceutical tablet of the present invention

[0086] 1) 15 g of Radix Ginseng and 5 g of Panax notoginseng were extracted three times with ethanol back flow, the extraction time was 3 hours, 3 hours, and 2 hours respectively, and the amount of alcohol added was 12 times, 10 times, and 8 times respectively, and the extracts were combined and filtered. After filtration, the filtrate recovers ethanol until it has no alcohol smell, adds water to an appropriate amount (so that each 1ml is equivalent to 1.5g of the original medicinal material), stirs well, refrigerates for 24 hours, filters, and extracts the filtrate with water-saturated n-butanol 3 times, all adding 1 times Measure n-butanol, combine the n-butanol liquid, recover n-butanol under reduced pressure to a thick paste, and dry under reduced pressure to obtain dry extract A.

[0087] 2) Grind 15g of Trichosanthes trichosanthes, pass through a 20-mesh sieve, add 4 times the amou...

Embodiment 2

[0090] Embodiment 2: the preparation of pharmaceutical composition capsule of the present invention

[0091] 1) 15 g of Radix Ginseng and 5 g of Panax notoginseng were extracted three times with ethanol back flow, the extraction time was 3 hours, 3 hours, and 2 hours respectively, and the amount of alcohol added was 12 times, 10 times, and 8 times respectively, and the extracts were combined and filtered. After filtration, the filtrate recovers ethanol until it has no alcohol smell, adds water to an appropriate amount (so that each 1ml is equivalent to 1.5g of the original medicinal material), stirs well, refrigerates for 24 hours, filters, and extracts the filtrate with water-saturated n-butanol 3 times, all adding 1 times Measure n-butanol, combine the n-butanol liquid, recover n-butanol under reduced pressure to a thick paste, and dry under reduced pressure to obtain dry extract A.

[0092] 2) Grind 15g of Trichosanthes trichosanthes, pass through a 20-mesh sieve, add 4 t...

Embodiment 3

[0094] Embodiment 3: the preparation of pharmaceutical composition granule of the present invention

[0095] 1) 15 g of Radix Ginseng and 5 g of Panax notoginseng were extracted three times with ethanol back flow, the extraction time was 3 hours, 3 hours, and 2 hours respectively, and the amount of alcohol added was 12 times, 10 times, and 8 times respectively, and the extracts were combined and filtered. After filtration, the filtrate recovers ethanol until it has no alcohol smell, adds water to an appropriate amount (so that each 1ml is equivalent to 1.5g of the original medicinal material), stirs well, refrigerates for 24 hours, filters, and extracts the filtrate with water-saturated n-butanol 3 times, all adding 1 times Measure n-butanol, combine the n-butanol liquid, recover n-butanol under reduced pressure to a thick paste, and dry under reduced pressure to obtain dry extract A.

[0096] 2) Grind 15g of Trichosanthes trichosanthes, pass through a 20-mesh sieve, add 4 t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, its preparation process and use, wherein the composition is prepared mainly from ginseng, pseudo-ginseng, pericarpium trichosanthis and ginkgo leaf. The composition can be made into any clinically and pharmaceutically acceptable dose forms, preferably oral preparations.

Description

1. Technical field [0001] The invention relates to a pharmaceutical composition mainly composed of ginseng, notoginseng and trichosanthes, and ginkgo leaves as well as its preparation method and application, belonging to the technical field of medicine. 2. Background technology [0002] Cardiovascular and cerebrovascular diseases include coronary heart disease, angina pectoris, myocardial infarction, congestive pulmonary heart disease, ischemic encephalopathy, cerebral thrombosis, hypertension, hyperlipidemia, etc. The main cause of these diseases is that arteriosclerosis causes narrowing of the lumen and blockage of the pipeline, which leads to insufficient blood supply to the heart and brain, causing symptoms such as dizziness, dizziness, headache, and chest tightness. In severe cases, it can lead to stroke and myocardial infarction. Cardiocerebral ischemia affects energy metabolism, secondary to various changes such as lactic acid accumulation, calcium overload, and free ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/428A61P9/10
Inventor 黄振华
Owner SHANDONG XUANZHU PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap